Role of Different Variants of Leptin Receptor in Human Adrenal Tumor Types
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25168682 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anna Klimont und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-356 Poznan, Poland. Hauptthemen laut MEDLINE: Receptors, Leptin, Adrenal Gland Neoplasms. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, the National Science Centre in Poland.
Abstract (Originalsprache)
The aim of the study was to evaluate the diagnostic and prognostic significance of leptin receptor isoforms in adrenal tumors. In a single-center study, 96 patients (19 with adrenal cortical carcinoma and 77 with benign tumors) underwent an adrenalectomy. A total of 14 unaffected adrenal gland tissues from kidney donors were used as controls. Fasting blood samples were collected for laboratory tests, and mRNA expressions of leptin receptor isoforms were assessed by RT-qPCR. The study analyzed correlations between mRNA expressions and clinical data and measured NCI-H295R cell proliferation via a real-time cell analyzer. All adrenal lesions expressed leptin receptor isoforms. Significantly lower LepR1 expression was observed in carcinoma tissues than in adenomas and controls (p = 0.016). Expressions of LepR3&LepR6 were correlated with overall survival (p = 0.036), while LepR2&LepR4 and LepR5 expressions were inversely related to morning serum cortisol levels (p = 0.041). Leptin reduced NCI-H295R cell proliferation (p < 0.0001). The study highlights the diagnostic and prognostic significance of leptin receptor isoforms in adrenal tumors. Specifically, LepR1 may serve as a diagnostic marker for carcinomas, while LepR3&LepR6 have potential use as prognostic markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-356 Poznan, Poland.
- Department of Histology and Embryology, Poznan University of Medical Sciences, 60-781 Poznan, Poland.
- Department of General, Endocrinological and Gastroenterological Surgery, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
- Department of General and Transplantation Surgery, Poznan University of Medical Sciences, 60-356 Poznan, Poland.
- Department of Clinical Pathology, Poznan University of Medical Sciences, 60-356 Poznan, Poland.
ORCID-Profile: Marcin Ruciński, Nadia Sawicka-Gutaj, Marta Szyszka, Małgorzata Blatkiewicz, Marek Ruchała, Hanna Komarowska
Förderung
- National Science Center
- the National Science Centre in Poland
Zitieren
APA
Klimont, A., Ruciński, M., Sawicka-Gutaj, N., Szyszka, M., Blatkiewicz, M., Wierzbicki, T., Karczewski, M., Janicka-Jedyńska, M., Ruchała, M., & Komarowska, H. (2024). Role of Different Variants of Leptin Receptor in Human Adrenal Tumor Types. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168682
Vancouver
Klimont A, Ruciński M, Sawicka-Gutaj N, Szyszka M, Blatkiewicz M, Wierzbicki T, et al. Role of Different Variants of Leptin Receptor in Human Adrenal Tumor Types. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168682
BibTeX
@article{Klimont2024,
author = {Klimont, Anna and Ruciński, Marcin and Sawicka-Gutaj, Nadia and Szyszka, Marta and Blatkiewicz, Małgorzata and Wierzbicki, Tomasz and Karczewski, Marek and Janicka-Jedyńska, Małgorzata and Ruchała, Marek and Komarowska, Hanna},
title = {Role of Different Variants of Leptin Receptor in Human Adrenal Tumor Types},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25168682}
}
EUVIMED